Get the app!
Back to Trades
Sell4

Arcutis Biotherapeutics, Inc.

ARQT

Total Value
$1.6M
Net $939.5K sold
Sales
$939.5K
2 transactions

Company Information

Ticker Symbol
ARQT
CIK
0001787306

Insider Information

Role
Director
Director
Location
WESTLAKE VILLAGE, CA

Filing Details

Filing Date
Nov 17, 2025
Transaction Date
Nov 13, 2025
Accession Number
0001866171-25-000007
Form Type
4
Net Trading Amount
-$939.5K

Non-Derivative Transactions

DateSecuritySharesPriceTypeValue
Nov 13, 2025Common Stock27,052$8.63Exercise$233.5K
Nov 13, 2025Common Stock12,220$7.51Exercise$91.8K
Nov 13, 2025Common Stock39,272$23.19Sale$910.7K
Nov 13, 2025Common Stock1,232$23.37Sale$28.8K

Derivative Transactions

DateSecuritySharesExercise PriceTypeValue
Nov 13, 2025Derivative27,052$8.63Exercise$233.5K
Nov 13, 2025Derivative12,220$7.51Exercise$91.8K

Footnotes

  1. (F1)The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 14, 2025, by the Reporting Person, with a plan end date of November 2, 2026.
  2. (F2)The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $22.86 to $23.60, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. (F3)The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service.
  4. (F4)The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.

SEC Filing

View on SEC Daily

View the complete filing document on SEC Daily.